X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (231) 231
humans (190) 190
glucose (146) 146
animals (138) 138
diabetes (111) 111
diabetes mellitus, type 2 - drug therapy (111) 111
sodium-glucose transporter 2 - antagonists & inhibitors (104) 104
male (101) 101
hypoglycemic agents - therapeutic use (88) 88
type 2 diabetes (88) 88
dextrose (79) 79
insulin (77) 77
dapagliflozin (76) 76
endocrinology & metabolism (75) 75
mice (69) 69
diabetes mellitus (68) 68
glucose - metabolism (66) 66
double-blind (65) 65
pharmacology & pharmacy (64) 64
hyperglycemia (63) 63
sodium (63) 63
female (56) 56
sodium-glucose transporter 2 - metabolism (55) 55
glucosides - therapeutic use (49) 49
hypoglycemic agents - pharmacology (46) 46
sodium-glucose transporter 1 - metabolism (46) 46
glucose metabolism (45) 45
hypoglycemic agents - adverse effects (44) 44
metabolism (43) 43
canagliflozin (42) 42
blood glucose - metabolism (41) 41
rodents (40) 40
insulin resistance (39) 39
empagliflozin (37) 37
glycemic control (37) 37
physiology (37) 37
analysis (36) 36
hypoglycemic agents (36) 36
middle aged (36) 36
sglt2 inhibitor (35) 35
diabetes mellitus, type 2 - metabolism (33) 33
inadequate glycemic control (33) 33
mellitus (33) 33
treatment outcome (33) 33
glucosides - pharmacology (32) 32
metformin (32) 32
safety (32) 32
type 2 diabetes mellitus (32) 32
diabetes mellitus, type 2 - blood (31) 31
expression (31) 31
rats (31) 31
sglt2 inhibitors (31) 31
blood glucose - drug effects (30) 30
drug therapy (30) 30
kidney (30) 30
adult (29) 29
blood sugar (29) 29
sglt2 (29) 29
benzhydryl compounds - therapeutic use (28) 28
glucose transporter (28) 28
hypoglycemic agents - administration & dosage (28) 28
kidneys (28) 28
diabetes mellitus, type 2 - complications (27) 27
patients (27) 27
glucosides - adverse effects (26) 26
mice, inbred c57bl (26) 26
biochemistry & molecular biology (25) 25
blood pressure (25) 25
risk factors (25) 25
sodium-glucose transporter 1 - genetics (25) 25
type-2 diabetes-mellitus (25) 25
inhibitors (24) 24
kidney - metabolism (24) 24
care and treatment (23) 23
ketoacidosis (23) 23
mice, knockout (23) 23
diabetes therapy (22) 22
efficacy (22) 22
health aspects (22) 22
hypoglycemia (22) 22
medicine & public health (22) 22
obesity (22) 22
research (22) 22
review (22) 22
add-on therapy (21) 21
diabetes mellitus, type 1 - drug therapy (21) 21
internal medicine (21) 21
aged (20) 20
homeostasis (20) 20
medicine (20) 20
sglt1 (20) 20
transporter (20) 20
benzhydryl compounds - adverse effects (19) 19
benzhydryl compounds - pharmacology (19) 19
body weight (19) 19
liver (19) 19
medicine, general & internal (19) 19
sodium-glucose transporter 1 (19) 19
article (18) 18
diabetic ketoacidosis - chemically induced (18) 18
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cellular Physiology and Biochemistry, ISSN 1015-8987, 07/2017, Volume 42, Issue 4, pp. 1358 - 1365
Background: Cellular glucose uptake may involve either non-concentrative glucose carriers of the GLUT family or Na+-coupled glucose-carrier SGLT1, which... 
Spleen | coupled glucose transport | Glucose uptake | TNF-α and IL-12a | Liver | Lung | Bacterial clearance | Listeria infection | Survival | Kidney | Na+-coupled glucose transport | CELLS | PHYSIOLOGY | TRANSPORTERS | GRANULOCYTES | INCREASES | CANCER | TNF-alpha and IL-12a | HYPERGLYCEMIA | METABOLISM | GLUCOSE-TRANSPORTER-1 | GLUCOSE COTRANSPORTER SGLT1 | EXPRESSION | Lung - microbiology | RNA, Messenger - immunology | Liver - pathology | Spleen - immunology | Kidney - pathology | Interleukin-12 - genetics | Tumor Necrosis Factor-alpha - genetics | Kidney - immunology | Liver - microbiology | Male | Sodium-Glucose Transporter 1 - genetics | Spleen - microbiology | Sodium-Glucose Transporter 1 - deficiency | Liver - immunology | Biological Transport | Gene Expression - immunology | Listeriosis - immunology | Tumor Necrosis Factor-alpha - immunology | Spleen - pathology | Lung - pathology | Listeriosis - mortality | Interleukin-6 - genetics | Glucose - immunology | Listeriosis - genetics | Mice, Inbred C57BL | RNA, Messenger - genetics | Listeria monocytogenes | Bacterial Load | Mice, Knockout | Kidney - microbiology | Animals | Interleukin-12 - immunology | Interleukin-6 - immunology | Survival Analysis | Glucose - metabolism | Listeriosis - microbiology | Mice | Sodium-Glucose Transporter 1 - immunology | Lung - immunology | Bacterial infections | Laboratories | Infections | Metabolism | Kinases | Small intestine | Listeria | Granulocytes | Lymphocytes | Rodents | Cancer | Index Medicus
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 03/2017, Volume 799, pp. 103 - 110
Journal Article
American Journal of Physiology - Cell Physiology, ISSN 0363-6143, 10/2017, Volume 313, Issue 4, pp. C421 - C429
Glucose constitutes a major source of energy of mammalian brains. Glucose uptake at the blood-brain barrier (BBB) occurs through a facilitated glucose... 
Blood-brain barrier | Stem cells | Glucose | blood-brain barrier | stem cells | LOCALIZATION | glucose | PHYSIOLOGY | GLUT1 DEFICIENCY | ALZHEIMERS-DISEASE | IN-VITRO MODELS | CELL BIOLOGY | METABOLISM | NEURONS | RAT-BRAIN | BARRIER-SPECIFIC PROPERTIES | DEFICIENCY SYNDROME | HYPOTHALAMUS | Glucose Transport Proteins, Facilitative - metabolism | Blood-Brain Barrier - cytology | Glucose Transporter Type 4 - metabolism | Humans | Microvessels - metabolism | Glucose Transporter Type 1 - metabolism | Glucose Transporter Type 3 - metabolism | Sodium-Glucose Transporter 1 - genetics | Glucose Transporter Type 3 - genetics | Sodium-Glucose Transporter 1 - metabolism | Glucose Transport Proteins, Facilitative - genetics | Diffusion | Induced Pluripotent Stem Cells - metabolism | Microvessels - cytology | Cell Line | Glucose Transporter Type 4 - genetics | Induced Pluripotent Stem Cells - drug effects | Endothelial Cells - metabolism | Microvessels - drug effects | Electric Impedance | Blood-Brain Barrier - drug effects | Symporters - metabolism | Blood-Brain Barrier - metabolism | Phenotype | Glucose Transporter Type 1 - genetics | Symporters - genetics | Glucose - metabolism | Glucose Transport Proteins, Facilitative - antagonists & inhibitors | Endothelial Cells - drug effects | Physiological aspects | Glucose metabolism | Endothelium
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 11, p. e108994
Background and Objective: Sodium glucose cotransporter 2 (SGLT2) is the main luminal glucose transporter in the kidney. SGLT2 inhibition results in glycosuria... 
CELLS | HYPERGLYCEMIA | SGLT2 | TRANSPORTERS | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | DISEASE | INJURY | PPAR-GAMMA AGONISTS | TRANSFORMING GROWTH FACTOR-BETA | PROGRESSION | Benzoates - therapeutic use | Toll-Like Receptor 2 - genetics | Diabetic Nephropathies - etiology | Transforming Growth Factor beta1 - metabolism | Glucose Transporter Type 1 - metabolism | Male | RNA, Messenger - metabolism | Nitric Oxide Synthase Type III - deficiency | Glucosides - therapeutic use | Chemokine CCL2 - metabolism | Diabetes Mellitus, Experimental - chemically induced | Diabetes Mellitus, Experimental - complications | Diabetes Mellitus, Experimental - metabolism | Benzhydryl Compounds - therapeutic use | Diabetic Nephropathies - prevention & control | Benzimidazoles - therapeutic use | Sodium-Glucose Transporter 2 - genetics | Hypoglycemic Agents - therapeutic use | Glucosides - pharmacology | Kidney Tubules, Proximal - pathology | Albuminuria - etiology | Blood Glucose - analysis | Sodium-Glucose Transporter 2 - metabolism | Diabetic Nephropathies - metabolism | Mice, Inbred C57BL | Chemokine CCL2 - genetics | Transforming Growth Factor beta1 - genetics | Toll-Like Receptor 2 - metabolism | Nitric Oxide Synthase Type III - genetics | Fibronectins - metabolism | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Hypoglycemic Agents - pharmacology | Mice, Knockout | Animals | Glucose Transporter Type 1 - genetics | Kidney Tubules, Proximal - metabolism | Benzoates - pharmacology | Benzimidazoles - pharmacology | Benzhydryl Compounds - pharmacology | Fibronectins - genetics | Mice | Streptozocin - toxicity | Blood Glucose - metabolism | Kidney Tubules, Proximal - drug effects | Drugs | Transcription | Syngeneic grafts | Streptozocin | Genomics | Transforming growth factor | Glucose | Macrophages | Blood | Fibronectin | Proteins | Atrophy | Hyperglycemia | Rodents | Toll-like receptors | Physiology | Inhibition | Protein transport | Immune system | Creatinine | Glucose transporter | Medical research | Kidneys | Cytokines | Diabetes mellitus | Reabsorption | Histology | Inflammation | Metabolism | Gene expression | Nephropathy | Sodium | Nitric oxide | Fibrosis | Angiotensin | Insulin resistance | Research design | Kidney diseases | Diabetes | Transporter | Monocyte chemoattractant protein 1 | Kidney transplantation | Best practice
Journal Article
American Journal of Physiology - Renal Physiology, ISSN 0363-6127, 08/2018, Volume 315, Issue 2, pp. F386 - F394
The sodium-glucose cotransporter SGLT2 inhibitor empagliflozin (plasma protein binding similar to 88%) may reach its target in the brush border of the early... 
Proximal tubule | Diabetes | Sodium glucose cotransport | Tubular secretion | Organic anion transporter | PHYSIOLOGY | tubular secretion | SEX | organic anion transporter | UROLOGY & NEPHROLOGY | MICE | SECRETION | proximal tubule | KIDNEY | SLC22A8 | diabetes | REABSORPTION | EXPRESSION | sodium glucose cotransport | Organic Anion Transporters, Sodium-Independent - genetics | Organic Anion Transport Protein 1 - metabolism | Sodium-Glucose Transporter 2 Inhibitors - pharmacology | Male | Glucosides - pharmacokinetics | Sodium-Glucose Transporter 2 Inhibitors - pharmacokinetics | Benzhydryl Compounds - urine | Glycosuria - prevention & control | Organic Anion Transporters, Sodium-Independent - metabolism | Sodium-Glucose Transporter 2 Inhibitors - urine | Benzhydryl Compounds - pharmacokinetics | Glucosides - pharmacology | Sodium-Glucose Transporter 2 - drug effects | Glomerular Filtration Rate | Glucosides - urine | Organic Anion Transporters, Sodium-Independent - deficiency | Glycosuria - genetics | Sodium-Glucose Transporter 2 - metabolism | Mice, Inbred C57BL | Organic Anion Transport Protein 1 - genetics | Glycosuria - metabolism | Mice, Knockout | Renal Elimination | Blood Glucose - drug effects | Animals | Kidney Tubules, Proximal - metabolism | Benzhydryl Compounds - pharmacology | Blood Glucose - metabolism | Kidney Tubules, Proximal - drug effects | Physiological aspects | Glucose | Carrier proteins | Kidney tubules | Dextrose | Index Medicus
Journal Article
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 03/2012, Volume 165, Issue 5, pp. 1361 - 1374
BACKGROUND AND PURPOSE Pentoxifylline is in clinical trials for non‐alcoholic fatty liver disease and diabetic nephropathy. Metabolic and hepatic effects of... 
glucose | ChREBP | pentoxifylline | methylxanthine | fatty liver | drug‐induced liver injury | obesity | drug-induced liver injury | TRIGLYCERIDE TRANSFER PROTEIN | ELEMENT-BINDING PROTEIN | FACTOR-KAPPA-B | NONALCOHOLIC STEATOHEPATITIS | DIET-INDUCED OBESITY | PARTIAL LEPTIN DEFICIENCY | CYCLIC-AMP | IN-VIVO | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | METABOLIC-DISORDERS | Glucose Transporter Type 2 - genetics | Humans | Intestinal Absorption - drug effects | Male | Adipocytes - drug effects | Glycolysis - drug effects | Jejunum - metabolism | Glycolysis - genetics | Jejunum - drug effects | Inflammation - metabolism | Lipogenesis - genetics | Liver - drug effects | Pentoxifylline - pharmacology | Biomarkers - metabolism | Fatty Liver - metabolism | Liver - metabolism | Biomarkers - blood | Blood Glucose - drug effects | Cell Line, Tumor | Glucose - metabolism | Blood Glucose - genetics | Mice, Obese | Transaminases - blood | Mice | Oxidative Stress - drug effects | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - genetics | Glucose Tolerance Test - methods | Diabetes Mellitus, Type 2 - metabolism | Obesity - genetics | Glucose Transporter Type 2 - metabolism | Sodium-Glucose Transporter 1 - genetics | Glycolysis - physiology | Lipids - blood | Sodium-Glucose Transporter 1 - metabolism | Nuclear Proteins - genetics | Sterol Regulatory Element Binding Protein 1 - metabolism | Fatty Liver - genetics | Mice, Inbred C57BL | Oxidative Stress - genetics | Glucose - genetics | Nuclear Proteins - metabolism | Transcription Factors - genetics | Obesity - metabolism | Transcription Factors - metabolism | Animals | Intestinal Absorption - genetics | Sterol Regulatory Element Binding Protein 1 - genetics | Adipocytes - metabolism | Lipogenesis - drug effects | Triglycerides - blood | Inflammation - genetics | Oxidative Stress | Biological Markers | Liver | Lipids | Adipocytes | Glucose | Intestinal Absorption | Life Sciences | Jejunum | Diabetes Mellitus, Type 2 | Lipogenesis | Pharmaceutical sciences | Obesity | Glucose Tolerance Test | Glucose Transporter Type 2 | Sodium-Glucose Transporter 1 | Blood Glucose | Inflammation | Triglycerides | Pharmacology | Nuclear Proteins | Pentoxifylline | Fatty Liver | Transaminases | Glycolysis | Transcription Factors | Sterol Regulatory Element Binding Protein 1 | Research Papers
Journal Article
Nutrition, ISSN 0899-9007, 2011, Volume 27, Issue 1, pp. 111 - 115
Journal Article